Testing cardiac patients for depression does not prove beneficial, reveals a new study.
Researchers at McGill University, Johns Hopkins University and six other institutions across the globe raised doubt on the American Heart Association's insistence on the important link between depression and cardiac care.
Cardiac Catheterization
Cardiac catheterization is a radiological procedure for both diagnosis and treatment of heart conditions. It involves the insertion of a long thin flexible tube called catheter a vein or an artery to the heart.
Advertisement
As per Dr. Brett Thombs, a psychologist and assistant professor in the Department of Psychiatry at McGill's Faculty of Medicine and at the affiliated Jewish General Hospital, there is not nearly enough medical evidence to support such a "massive, expensive and labour-intensive undertaking."
The study examined a collection of more than 1,500 clinical studies from around the world and after reviewing 17 of these in detail, Dr. Roy Ziegelstein, of Johns Hopkins added screening for depression would not held patients in a cardiac care environment.
![Steps to Block Key Enzyme Action in Heart Failure Mapped]( "Steps to Block Key Enzyme Action in Heart Failure Mapped")
In a breakthrough study, scientists at Johns Hopkins have mapped out a key chemical step involved in blocking enzyme action in heart failure.
Thombs said: "We discovered that screening alone or screening and referral doesn't help most patients. Moreover, we found no connection at all between getting treated for depression and cardiovascular outcomes, like having a subsequent heart attack.
"That said, in no sense are we saying that depression doesn't matter. We're just saying we don't have the tools in cardiovascular care settings to identify and improve the lives of people who aren't already being treated for depression.
The study is to be published in the Nov. 12 special edition of the Journal of the American Medical Association (JAMA).
Source: ANI
SK
Steps to Block Key Enzyme Action in Heart Failure Mapped
In a breakthrough study, scientists at Johns Hopkins have mapped out a key chemical step involved in blocking enzyme action in heart failure.
Advertisement
Thombs said: "We discovered that screening alone or screening and referral doesn't help most patients. Moreover, we found no connection at all between getting treated for depression and cardiovascular outcomes, like having a subsequent heart attack.
"That said, in no sense are we saying that depression doesn't matter. We're just saying we don't have the tools in cardiovascular care settings to identify and improve the lives of people who aren't already being treated for depression.
The study is to be published in the Nov. 12 special edition of the Journal of the American Medical Association (JAMA).
Source: ANI
SK
Bypass Heart Surgery Does Not Affect Kids' IQ Levels
Bypass surgery in children with less complex heart defects doesn't lead to low IQ levels, say researchers from the Children's Hospital of Philadelphia.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Research News
Light therapy enhances sleep and psycho-behavioral symptoms in Alzheimer's patients with minimal side effects.
Electrical stimulation improves Alzheimer's patients' cognitive function and correlates with restored cortical plasticity.
South Korea's total fertility rate, averaging the number of children a woman aged 15-49 has in her lifetime, dropped to 0.81.
Scientists identified mechanisms governing immune cells, selectively removing troublemakers to reshape skin immunity. Benefits those with psoriasis, vitiligo.
By 2050, an anticipated increase from 494 million cases in 2020 to 1.06 billion people with musculoskeletal disabilities is expected.